73 research outputs found
Inhibitory Effects of Skin Permeable Glucitol-core Containing Gallotannins from Red Maple Leaves on Elastase and their Protective Effects on Human Keratinocytes
Glucitol-core containing gallotannins (GCGs) from the red maple (Acer rubrum) species have been reported to exhibit skin beneficial activities but their inhibitory effects on elastase remain unclear. Herein, we evaluated a series of GCGs for their anti-elastase activity, skin permeability, and cytoprotective effects in human keratinocytes HaCaT cells. GCGs’ anti-elastase effects were enhanced as their number of galloyl groups increased, which may be attributed to the formation of more stable protein–ligand complexes. In addition, GCGs were predicted to have moderate skin permeability and ginnalin A (GA) showed favorable permeability in the PAMPA model and cell uptake assay. Moreover, GA, ginnalin B, and maplexin F (at 50 µM) reduced H2O2-induced reactive oxygen species in HaCaT cells by 70.8, 92.8, and 84.6%, respectively. In conclusion, red maple GCGs are skin permeable elastase inhibitors with antioxidant activity, which may contribute to their overall skin beneficial effects and support their potential for cosmeceutical applications
ROR1 and ROR2 expression in pancreatic cancer
Background: The Wnt receptors ROR1 and ROR2 are generating increased interest as cancer therapeutic targets but remain understudied in pancreatic ductal adenocarcinoma (PDAC). Compared to canonical Wnt/ β-catenin signalling, the role of noncanonical Wnt signalling in PDAC remains largely unknown. Only one study has investigated the prognostic significance of the noncanonical Wnt signalling receptor, ROR2 in PDAC. No studies have investigated the prognostic role of ROR1 in PDAC. Methods: Here, we performed analysis of ROR1 and ROR2 mRNA expression in three publicly available datasets ICGC-PACA-AU (n = 81), TCGA-PAAD (n = 150) and CPTAC-PDAC (n = 137). ROR1 and ROR2 protein expression from the CPTAC-PDAC discovery cohort were also analysed. Immunohistochemistry (IHC) using the validated anti ROR1 monoclonal antibody (4A5) was performed on the Australian Pancreatic Cancer Genome Initiative (APGI) cohort of PDAC samples (n = 152). Association between ROR1 cytoplasmic staining intensity and clinicopathological
parameters including stage, grade and overall survival (OS) was investigated. Results: High ROR1 mRNA expression levels correlated with a favourable OS outcome in all of the ICGC-PACA-AU, TCGA-PAAD and CPTAC-PDAC cohorts. ROR1 protein expression was not associated with stage, grade or OS in the APGI cohort. Conclusion: ROR1 and ROR2 have potential as prognostic markers when measured at the mRNA level in PDAC. Our IHC cohort did not support ROR1 protein expression in predicting OS, and highlighted the discrepancy of prognostic biomarkers when measured by MS, IHC and RNAseq
Structural Basis of Chemokine Sequestration by CrmD, a Poxvirus-Encoded Tumor Necrosis Factor Receptor
Pathogens have evolved sophisticated mechanisms to evade detection and destruction by the host immune system. Large DNA viruses encode homologues of chemokines and their receptors, as well as chemokine-binding proteins (CKBPs) to modulate the chemokine network in host response. The SECRET domain (smallpox virus-encoded chemokine receptor) represents a new family of viral CKBPs that binds a subset of chemokines from different classes to inhibit their activities, either independently or fused with viral tumor necrosis factor receptors (vTNFRs). Here we present the crystal structures of the SECRET domain of vTNFR CrmD encoded by ectromelia virus and its complex with chemokine CX3CL1. The SECRET domain adopts a β-sandwich fold and utilizes its β-sheet I surface to interact with CX3CL1, representing a new chemokine-binding manner of viral CKBPs. Structure-based mutagenesis and biochemical analysis identified important basic residues in the 40s loop of CX3CL1 for the interaction. Mutation of corresponding acidic residues in the SECRET domain also affected the binding for other chemokines, indicating that the SECRET domain binds different chemokines in a similar manner. We further showed that heparin inhibited the binding of CX3CL1 by the SECRET domain and the SECRET domain inhibited RAW264.7 cell migration induced by CX3CL1. These results together shed light on the structural basis for the SECRET domain to inhibit chemokine activities by interfering with both chemokine-GAG and chemokine-receptor interactions
The Cultural Difference on the Evaluation of Political Leader: Comparison between Korean and Chinese College Students
Determination of pesticides and Pharmaceuticals from Fish Cultivation Water by parallel solid-phase extraction (SPE) and liquid chromatography–quadrupole time-of-flight mass spectrometry (LC-QTOF-MS)
- …